Vandetanib - PDFSEARCH.IO - Document Search Engine

Vandetanib
Results: 29

#	Item
1	M AY 1 9 , — L A U R I E E . G A S PA R , M D, M B A UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, AURORA, CO I D E N T I F Y I N G I N F O R M AT I O N G A P S A N D G A I N I N G PAT I E N T P E R S P E C T I V Add to Reading List Source URL: www.lungcancerfoundation.org Language: English - Date: 2015-05-04 19:36:17 Lung cancer Eli Lilly and Company Cancer Occupational safety and health Pathology Nicholas Thatcher Vandetanib Medicine Chemistry Organic chemistry
2	CAPRELSA® (vandetanib) Tablets HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CAPRELSA safely and effectively. See full prescribing Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-10-15 15:54:06 Organofluorides Piperazines Cardiac dysrhythmia Cyclopropanes Torsades de pointes Norfloxacin Pimozide Moxifloxacin QT interval Chemistry Organic chemistry Janssen Pharmaceutica
3	cabozantinib 20mg and 80mg hard capsules (Cometriq®) Swedish Orphan Biovitrum Ltd. SMC No[removed]February 2015 Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Oncology Organofluorides Medullary thyroid cancer Cabozantinib Vandetanib Thyroid neoplasm Multiple endocrine neoplasia End point of clinical trials Metastasis Medicine Thyroid cancer Chemistry
4	CAPRELSA® (vandetanib) Tablets Add to Reading List Source URL: www.fda.gov Language: English Amines Alcohols Amiodarone Darunavir Chemistry Organic chemistry Piperazines
5	Microsoft Word - DAC_2014Q1_meeting_outcome_Eng.docx Add to Reading List Source URL: www.ha.org.hk Language: English Angiogenesis inhibitors Benzazepines Ivabradine Lactams Servier Eculizumab Bevacizumab Olmesartan Vandetanib Chemistry Organic chemistry Orphan drugs
6	Signatory Authority Decisional Memorandum to the File Add to Reading List Source URL: www.fda.gov Language: English Chemistry Organofluorides Medullary thyroid cancer Angiogenesis inhibitors Vandetanib Response Evaluation Criteria in Solid Tumors End point of clinical trials Thyroid neoplasm Multiple endocrine neoplasia Medicine Oncology Thyroid cancer
7	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Source URL: www.fda.gov Language: English Organic chemistry Organofluorides AstraZeneca Organobromides Quinazolines Vandetanib Medullary thyroid cancer Thyroid neoplasm Protein kinase inhibitor Thyroid cancer Chemistry Medicine
8	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Source URL: www.fda.gov Language: English Intensive care medicine Organ failure Infectious diseases Heart diseases Vandetanib Respiratory failure Heart failure Pneumonia Sepsis Medicine Health Medical emergencies
9	Microsoft PowerPoint - Supportive Slides [Compatibility Mode] Add to Reading List Source URL: www.fda.gov Language: English Organofluorides AstraZeneca Organobromides Piperidines Vandetanib Medullary thyroid cancer Thyroid neoplasm Protein kinase inhibitor Radiation therapy Medicine Chemistry Thyroid cancer
10	Errata to the FDA Briefing Package Add to Reading List Source URL: www.fda.gov Language: English Logrank test Vandetanib Proportional hazards models Progression-free survival Hazard ratio Hazard AstraZeneca Statistics Survival analysis Chemistry